<div align="center">
  <img src="/profile/logo.svg" alt="EMBL Logo" width="150"/>
  <h1>Michael Zimmermann Group</h1>
  <h3>Molecular Systems Biology unit | EMBL Heidelberg</h3>
  
  <p>
    <b>Metabolic microbiome-host interactions</b>
  </p>

  <a href="https://www.embl.org/groups/zimmermann/">
    <img src="https://img.shields.io/badge/Visit-Lab%20Website-007C80?style=for-the-badge&logo=googlechrome&logoColor=white" alt="Website">
  </a>
  <a href="https://bsky.app/profile/zimmermannlab.bsky.social">
    <img src="https://img.shields.io/badge/Follow-BLUESKY-1DA1F2?style=for-the-badge&logo=twitter&logoColor=white" alt="bsky">
  </a>
</div>

<br />

> **Our Mission:** We mechanistically map metabolic interactions between the host and its microbiome. By using high-throughput mass spectrometry, we unravel how gut microbes recognise and transform environmental chemicals and medical drugs.

---

#### ðŸ¦  Microbiome & Modeling

#### ðŸ§ª Metabolomics & Data Analysis

---

### ðŸ’» Tech Stack

<div align="center">
<img src="https://img.shields.io/badge/PYTHON-gradient?style=for-the-badge&logo=python&logoColor=white&labelColor=3776AB&color=FFD43B" alt="Python"></a>
<img src="https://img.shields.io/badge/R-gradient?style=for-the-badge&logo=r&logoColor=white&labelColor=276DC3&color=75AADB" alt="R"></a>
<img src="https://img.shields.io/badge/DOCKER-gradient?style=for-the-badge&logo=docker&logoColor=white&labelColor=2496ED&color=099CEC" alt="Docker"></a>
<img src="https://img.shields.io/badge/NEXTFLOW-gradient?style=for-the-badge&logo=nextflow&logoColor=white&labelColor=27BA6C&color=41E29F" alt="Nextflow"></a>
<img src="https://img.shields.io/badge/METABOLOMICS-gradient?style=for-the-badge&logo=graphql&logoColor=white&labelColor=4B0082&color=9932CC" alt="Metabolomics"></a>
</div>

---

### ðŸ“° Recent Highlights
* **Publication:** *Development of a GC-MS/MS method to quantify 120 gut microbiota-derived metabolites* (Springer Nature, 2025). [Read Article](https://link.springer.com/article/10.1007/s00216-025-06256-6)
* * **Publication:** *Gut bacteria generate prodrugs in situ increasing systemic drug exposure* (bioRxiv, 2025). [Read Article](https://www.biorxiv.org/content/10.64898/2025.12.09.692405v1))
* **Publication:** *Gut microbiota carcinogen metabolism causes distal tissue tumours* (Nature, 2024). [Read Article](https://www.nature.com/articles/s41586-024-07754-w)
* **Publication:** *Unraveling interindividual differences and functional consequences of gut microbial metabolism of immunosuppressants* (biRxXiv, 2024). [Read Article](https://www.biorxiv.org/content/10.1101/2024.03.28.586928v4)
---

<div align="center">
  <sub><b>European Molecular Biology Laboratory (EMBL)</b><br>
  MeyerhofstraÃŸe 1, 69117 Heidelberg, Germany<br>
  Â© Zimmermann Group 2025</sub>
</div>
